Website Information
    Web Site Information :.   Site Info    Whois    Traceroute    RBL Check  

Enter Web Site URL Address:
 

farmacopedia.fr: Guide des Médicaments de France
farmacopedia.fr - Guide des Médicaments de France  
 
 

Guide des Médicaments de France

Description: farmacopedia.fr - Guide des Médicaments de France

Keywords: médicaments, principe actif, laboratoire, classe thérapeutique, guide des médicaments, liste alphabétique

Tags: farmacopedia, inicio, des, médicaments, guide, france, alphabétique, liste, thérapeutique, classe, actif, principe, laboratoire, information, dans, amm, absence, comprimé, rond, pathologie, blanc, sur, merck, aciclovir, alter, les, sodium, biomag, alprazolam, abcès, arrow, sandoz, face, gélule, une,

Farmacopedia.fr

Content Revalency: Title: 80.00%   Description: 71.43%   Keywords: 80.00%  |  Document size: 21,324 bytes
More info: Whois - Trace Route - RBL Check
 
FARMACOPEDIA.FR - Site Location
Country/Flag US United States
City/Region/Zip Code Spring, TX, 77393
Organization Landis Holdings
Internet Service Provider Landis Holdings
 
FARMACOPEDIA.FR - Domain Information
Domain farmacopedia.fr   [ Traceroute  RBL/DNSBL lookup ]
Registrar INSTRA CORPORATION PTY LTD INSTRA CORPORATION PTY LTD INSTRA CORPORATION PTY LTD INSTRA CORPORATION PTY LTD
Whois server whois.nic.fr
Created 03-Jun-2009
Updated 11-May-2015
Expires --
Time Left 0 days 0 hours 0 minutes
Status ACTIVE ok ok ok
DNS servers ns2.farmacodns.com   209.217.237.174
ns1.farmacodns.com   209.217.237.172
 
FARMACOPEDIA.FR - DNS Information
IP Address 209.217.237.172 ~ Whois - Trace Route - RBL Check
Domain Name Servers ns2.farmacodns.com  
ns1.farmacodns.com  
Mail Exchange farmacopedia.fr  
 
Site Response Header
Response HTTP/1.1 200 OK
Server Apache/2.2.11 (Unix) mod_ssl/2.2.11 OpenSSL/0.9.8e-fips-rhel5 mod_auth_passthrough/2.1 mod_bwlimited/1.4 FrontPage/5.0.2.2635 PHP/5.2.9
Date Mon, 11 Apr 2011 10:39:54 GMT
Content-Type text/html


  IP Index    TLD Index    Domain Index    Site Index New   Copyright © 2024 Cybernet Quest.